Literature DB >> 34150108

Effects of Yu-ping-feng granules combined with loratadine tablets on treatment efficacy and immune factor levels in allergic rhinitis patients.

Jinlan Song1.   

Abstract

OBJECTIVE: This study was designed to explore the treatment efficacy of Yu-ping-feng combined with loratadine in allergic rhinitis patients.
METHODS: A total of 88 patients with allergic rhinitis who were admitted to our hospital from July 2017 to September 2018 were collected as research subjects, 43 of whom were enrolled in group A and treated with loratadine, and another 45 cases were enrolled in group B and treated with Yu-ping-feng combined with loratadine. The immune factors and ventilation function of the two groups were observed, as well as the treatment efficacy, adverse reactions and quality of life of the two groups of patients.
RESULTS: After treatment, the immune factor level and ventilation function in group B were better than those in group A (P < 0.05). The total adverse reactions and recurrence rate in group B were lower than those in group A (P < 0.05). The total effective rate and quality of life in group B were higher than those in group A (P < 0.05).
CONCLUSION: Yu-ping-feng granules combined with loratadine tablets is effective in treating allergic rhinitis. AJTR
Copyright © 2021.

Entities:  

Keywords:  Loratadine tablets; allergic rhinitis; efficacy; immune factors

Year:  2021        PMID: 34150108      PMCID: PMC8205798     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  27 in total

1.  Ecotoxic effects of loratadine and its metabolic and light-induced derivatives.

Authors:  Maria Rosaria Iesce; Margherita Lavorgna; Chiara Russo; Concetta Piscitelli; Monica Passananti; Fabio Temussi; Marina DellaGreca; Flavio Cermola; Marina Isidori
Journal:  Ecotoxicol Environ Saf       Date:  2018-12-20       Impact factor: 6.291

Review 2.  Asthma and allergic rhinitis in childhood: what's new.

Authors:  Carla Mastrorilli; Daniela Posa; Francesca Cipriani; Carlo Caffarelli
Journal:  Pediatr Allergy Immunol       Date:  2016-12       Impact factor: 6.377

3.  Histamine H1 type receptor antagonist loratadine ameliorates oxidized LDL induced endothelial dysfunction.

Authors:  Yuyang Zhou; Chengshan Gao; Hongshan Wang; Lei Liu; Zhenfeng Huang; Xianen Fa
Journal:  Biomed Pharmacother       Date:  2018-07-24       Impact factor: 6.529

4.  [Effect of Yupingfeng granule on cytokines of allergic rhinitis induced by OVA in rats].

Authors:  Lei Tong; Jin-Li Liu; Jing-Xin Wang; Lin-Lin Sun; Yi-Ling Song; Gui-Yuan Tian; Shuai He; Yue-Juan Gao
Journal:  Zhongguo Zhong Yao Za Zhi       Date:  2016-02

5.  Theoretical investigation of loratadine reactivity in order to understand its degradation properties: DFT and MD study.

Authors:  Stevan Armaković; Sanja J Armaković; Biljana F Abramović
Journal:  J Mol Model       Date:  2016-09-17       Impact factor: 1.810

Review 6.  Adjuvant Treatment with Yupingfeng Formula for Recurrent Respiratory Tract Infections in Children: A Meta-analysis of Randomized Controlled Trials.

Authors:  Tao Song; Xiaoli Hou; Xiaohui Yu; Zhen Wang; Ruiren Wang; Yanling Li; Dan Hu; Xiaohong Wang; Zhengzheng Xiao; Yong Sui; Chunhong Zhu; Jing Wang
Journal:  Phytother Res       Date:  2016-05-04       Impact factor: 5.878

7.  Fermented Yupingfeng polysaccharides enhance immunity by improving the foregut microflora and intestinal barrier in weaning rex rabbits.

Authors:  Hao Sun; Xueqin Ni; Xu Song; Bin Wen; Yi Zhou; Fuqin Zou; Mingyue Yang; Zhirong Peng; Hui Zhu; Yan Zeng; Hesong Wang; Xiangchao Fu; Yunduo Shi; Zhongqiong Yin; Kangcheng Pan; Bo Jing; Dong Zeng; Ping Wang
Journal:  Appl Microbiol Biotechnol       Date:  2016-06-04       Impact factor: 4.813

8.  Effects of YuPingFeng granules on acute exacerbations of COPD: a randomized, placebo-controlled study.

Authors:  Jinfang Ma; Jinping Zheng; Nanshan Zhong; Chunxue Bai; Haoyan Wang; Juan Du; Fenglei Li; Yanwei Chen; Zhe Shi; Xin Li; Pingyan Chen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-10-04

Review 9.  Modulation of Allergic Inflammation in the Nasal Mucosa of Allergic Rhinitis Sufferers With Topical Pharmaceutical Agents.

Authors:  Annabelle M Watts; Allan W Cripps; Nicholas P West; Amanda J Cox
Journal:  Front Pharmacol       Date:  2019-03-29       Impact factor: 5.810

10.  TOTALL: high cost of allergic rhinitis-a national Swedish population-based questionnaire study.

Authors:  Lars-Olaf Cardell; Petter Olsson; Morgan Andersson; Karl-Olof Welin; Johanna Svensson; Gunnel Ragnarson Tennvall; Johan Hellgren
Journal:  NPJ Prim Care Respir Med       Date:  2016-02-04       Impact factor: 2.871

View more
  1 in total

1.  Efficacy and Safety of Modified Yupingfeng Nasal Spray in Controlling the Recurrence of Persistent and Moderate-Severe Allergic Rhinitis: Study Protocol for a Multicenter, Open-Label, Randomized, and Parallel-Arm Trial.

Authors:  Ting Liu; Bing-Qing Lu; Dan-Dan Wang; Chao Liao; Han-Jen Chiang; Rong Zhang; Yuan Xi; Li Tian
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-10       Impact factor: 2.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.